# Sarah Francis

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sarah-francis/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,714 |
| Field | Food Security and Health in Diverse Populations |
| h-index | 23 |
| i10-index | 52 |
| Last Known Institution | Iowa State University |
| OpenAlex ID | https://openalex.org/A5063372633 |
| ORCID iD | 0000-0001-7761-5220 |
| Works | 155 |

## Researcher papers

- [Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study](https://scholariq.org/papers/physical-cognitive-and-mental-health-impacts-of-covid-19-after-hospitalisation/)
- [Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/azithromycin-in-patients-admitted-to-hospital-with-covid-19-recovery-a/)
- [Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial](https://scholariq.org/papers/convalescent-plasma-in-patients-admitted-to-hospital-with-covid-19-recovery-a/)
- [Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study](https://scholariq.org/papers/clinical-characteristics-with-inflammation-profiling-of-long-covid-and/)
- [Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/casirivimab-and-imdevimab-in-patients-admitted-to-hospital-with-covid-19/)
- [Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis](https://scholariq.org/papers/baricitinib-in-patients-admitted-to-hospital-with-covid-19-recovery-a-randomised/)
- [Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/aspirin-in-patients-admitted-to-hospital-with-covid-19-recovery-a-randomised/)
- [GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19](https://scholariq.org/papers/gwas-and-meta-analysis-identifies-49-genetic-variants-underlying-critical-covid/)
- [Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/higher-dose-corticosteroids-in-patients-admitted-to-hospital-with-covid-19-who/)
- [SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination](https://scholariq.org/papers/sars-cov-2-specific-nasal-iga-wanes-9-months-after-hospitalisation-with-covid-19/)
- [Determinants of Human Papillomavirus Vaccine Acceptance among Caregivers in Nigeria: A Fogg Behavior Model-Based Approach](https://scholariq.org/papers/determinants-of-human-papillomavirus-vaccine-acceptance-among-caregivers-in/)

## Researcher topics

- [Food Security and Health in Diverse Populations](https://scholariq.org/topics/food-security-and-health-in-diverse-populations/)
- [Obesity, Physical Activity, Diet](https://scholariq.org/topics/obesity-physical-activity-diet/)
- [Nutrition and Health in Aging](https://scholariq.org/topics/nutrition-and-health-in-aging/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Nutrition, Health and Food Behavior](https://scholariq.org/topics/nutrition-health-and-food-behavior/)

## Researcher university

- [Iowa State University](https://scholariq.org/institutions/iowa-state-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.